Hotchkis & Wiley Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $192M | Sell |
3,482,054
-175,877
| -5% | -$9.53M | 0.59% | 52 |
|
|
2025
Q4 | $179M | Sell |
3,657,931
-944,270
| -21% | -$44M | 0.54% | 57 |
|
|
2025
Q3 | $199M | Buy |
4,602,201
+45,580
| +1% | +$1.78M | 0.62% | 50 |
|
|
2025
Q2 | $175M | Sell |
4,556,621
-81,428
| -2% | -$3.11M | 0.57% | 55 |
|
|
2025
Q1 | $180M | Sell |
4,638,049
-3,240
| -0.1% | -$119K | 0.6% | 52 |
|
|
2024
Q4 | $157M | Buy |
4,641,289
+1,099,146
| +31% | +$39.6M | 0.52% | 53 |
|
|
2024
Q3 | $145M | Buy |
3,542,143
+833,080
| +31% | +$34.1M | 0.48% | 55 |
|
|
2024
Q2 | $104M | Sell |
2,709,063
-30,217
| -1% | -$1.27M | 0.36% | 69 |
|
|
2024
Q1 | $117M | Sell |
2,739,280
-10,066
| -0.4% | -$415K | 0.39% | 64 |
|
|
2023
Q4 | $102M | Sell |
2,749,346
-82,570
| -3% | -$2.96M | 0.36% | 65 |
|
|
2023
Q3 | $103M | Sell |
2,831,916
-33,650
| -1% | -$1.19M | 0.39% | 59 |
|
|
2023
Q2 | $102M | Sell |
2,865,566
-28,200
| -1% | -$1.01M | 0.38% | 68 |
|
|
2023
Q1 | $103M | Sell |
2,893,766
-32,220
| -1% | -$1.13M | 0.4% | 63 |
|
|
2022
Q4 | $103M | Sell |
2,925,986
-69,272
| -2% | -$2.31M | 0.39% | 63 |
|
|
2022
Q3 | $88.2M | Sell |
2,995,258
-638,324
| -18% | -$24.2M | 0.38% | 66 |
|
|
2022
Q2 | $198M | Sell |
3,633,582
-2,974,587
| -45% | -$164M | 0.79% | 41 |
|
|
2022
Q1 | $360M | Sell |
6,608,169
-290,720
| -4% | -$15.8M | 1.15% | 26 |
|
|
2021
Q4 | $380M | Sell |
6,898,889
-401,857
| -6% | -$20.9M | 1.2% | 28 |
|
|
2021
Q3 | $349M | Sell |
7,300,746
-334,160
| -4% | -$16.8M | 1.11% | 32 |
|
|
2021
Q2 | $380M | Sell |
7,634,906
-509,174
| -6% | -$24.5M | 1.16% | 31 |
|
|
2021
Q1 | $363M | Sell |
8,144,080
-146,480
| -2% | -$6.65M | 1.11% | 35 |
|
|
2020
Q4 | $381M | Buy |
8,290,560
+2,366,960
| +40% | +$109M | 1.33% | 27 |
|
|
2020
Q3 | $279M | Buy |
5,923,600
+145,280
| +3% | +$7.28M | 1.27% | 29 |
|
|
2020
Q2 | $295M | Sell |
5,778,320
-128,310
| -2% | -$6.58M | 1.37% | 26 |
|
|
2020
Q1 | $280M | Buy |
5,906,630
+8,480
| +0.1% | +$452K | 1.57% | 19 |
|
|
2019
Q4 | $346M | Buy |
5,898,150
+570,264
| +11% | +$31.7M | 1.2% | 31 |
|
|
2019
Q3 | $284M | Sell |
5,327,886
-812,920
| -13% | -$41.8M | 1.15% | 31 |
|
|
2019
Q2 | $307M | Buy |
6,140,806
+376,240
| +7% | +$18.9M | 1.18% | 31 |
|
|
2019
Q1 | $301M | Sell |
5,764,566
-115,120
| -2% | -$5.75M | 1.18% | 32 |
|
|
2018
Q4 | $281M | Sell |
5,879,686
-854,723
| -13% | -$42.1M | 1.24% | 31 |
|
|
2018
Q3 | $338M | Buy |
6,734,409
+36,849
| +0.6% | +$1.87M | 1.21% | 29 |
|
|
2018
Q2 | $337M | Sell |
6,697,560
-138,062
| -2% | -$6.95M | 1.27% | 28 |
|
|
2018
Q1 | $334M | Buy |
6,835,622
+107,200
| +2% | +$4.99M | 1.32% | 24 |
|
|
2017
Q4 | $298M | Sell |
6,728,422
-5,120
| -0.1% | -$237K | 1.13% | 30 |
|
|
2017
Q3 | $342M | Buy |
6,733,542
+455,680
| +7% | +$23.1M | 1.35% | 26 |
|
|
2017
Q2 | $338M | Buy |
6,277,862
+258,160
| +4% | +$13.8M | 1.36% | 26 |
|
|
2017
Q1 | $317M | Sell |
6,019,702
-226,058
| -4% | -$11.5M | 1.24% | 28 |
|
|
2016
Q4 | $301M | Sell |
6,245,760
-274,562
| -4% | -$13.6M | 1.21% | 27 |
|
|
2016
Q3 | $352M | Sell |
6,520,322
-231,189
| -3% | -$12.7M | 1.47% | 23 |
|
|
2016
Q2 | $366M | Sell |
6,751,511
-380,747
| -5% | -$20.1M | 1.56% | 20 |
|
|
2016
Q1 | $362M | Sell |
7,132,258
-2,550,077
| -26% | -$127M | 1.52% | 20 |
|
|
2015
Q4 | $488M | Sell |
9,682,335
-238,372
| -2% | -$12.2M | 1.98% | 12 |
|
|
2015
Q3 | $477M | Buy |
9,920,707
+628,330
| +7% | +$32.7M | 1.91% | 10 |
|
|
2015
Q2 | $484M | Sell |
9,292,377
-550,003
| -6% | -$31M | 1.71% | 12 |
|
|
2015
Q1 | $568M | Buy |
9,842,380
+71,272
| +0.7% | +$4.09M | 1.97% | 8 |
|
|
2014
Q4 | $522M | Buy |
9,771,108
+1,127,457
| +13% | +$63.1M | 1.82% | 12 |
|
|
2014
Q3 | $497M | Buy |
8,643,651
+4,684,357
| +118% | +$287M | 1.81% | 15 |
|
|
2014
Q2 | $265M | Buy |
3,959,294
+3,929,876
| +13,359% | +$266M | 0.94% | 36 |
|
|
2014
Q1 | $1.97M | Buy |
+29,418
| New | +$1.99M | 0.01% | 172 |
|
Other funds holding GSK
JEST
